多模态成像市场规模、份额、成长分析（按技术、按应用、按地区）- 产业预测，2024-2031 年

全球多模态成像市场规模预计从 2023 年的 41 亿美元成长到 2022 年约 39 亿美元，预测期内（2024-2031 年）复合年增长率为 5.6%，预计 2031 年将达到 63 亿美元。预计将达到10亿美元。

随着 SPECT/CT、PET/MR 和 PET/CT 等多种成像技术的整合增强了与癌症、眼科和神经系统疾病相关的诊断能力，多模态影像市场预计将显着成长。推动这一市场的关键因素包括诊断影像技术的快速进步、人口老化、医疗保健成本上升以及慢性病盛行率上升。从 2021 年到 2028 年，技术发展和现代医疗保健实践的创新预计将为多模态成像应用创造更多商机。随着新型显影剂、先进检测器和电脑辅助工具的推出，该领域正在适应不断变化的消费者需求，并确保为患者提供准确的治疗。此外，先进多模态成像技术的发展，例如利用双功能化学染料的混合光声萤光成像，已显示出提高诊断准确性的潜力。随着奈米粒子的成长，对具有可调频谱和光稳定性的混合显影剂的需求不断增长，支撑了市场的收益动力。然而，多模态成像设备的高成本和医疗基础设施不足等挑战可能会阻碍成长。儘管存在这些障碍，美国多模态成像市场预计未来几年将以永续的复合年增长率成长，随着医疗保健动态的发展呈现出坚韧的前景。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 价值链分析
• 供应链分析
• 专利分析
• 贸易分析
• 技术分析
• 案例研究分析
• 价格分析

多模态成像市场：依技术分类

• 市场概况
• PET/CT系统
• SPECT/CT系统
• PET/MR系统
• OCT/FMT系统
• 其他多模态成像系统

多模态成像市场：依应用分类

• 市场概况
• 肿瘤学
• 心臟病学
• 眼科
• 脑和神经病学
• 研究
• 其他用途

多模态成像市场：依最终用户划分

• 市场概况
• 医院
• 影像诊断中心
• 学术研究所
• 其他最终用户

多模态成像市场规模：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• GE Healthcare
• Koninklijke Philips NV
• Canon Medical Systems Corporation
• Siemens Healthineers
• Zeiss Group
• Bruker
• Mediso Ltd.
• Neusoft Corporation
• Infraredx, Inc.（part of Nipro Corporation）
• Topcon Corporation
• Shanghai United Imaging Healthcare Co., Ltd.
• Heidelberg Engineering
• Spectrum Dynamics Medical
• Minfound Medical Systems Co., Ltd.
• Kindsway Biotech
• Sofie Biosciences, Inc.
• Fujifilm Corporation.

Global Multimodal Imaging Market size was valued at around USD 3.9 billion in 2022 and is expected to rise from USD 4.1 billion in 2023 to reach a value of USD 6.3 billion by 2031, at a CAGR of 5.6% over the forecast period (2024-2031).

The multimodal imaging market is poised for substantial growth, driven by the integration of multiple imaging technologies such as SPECT/CT, PET/MR, and PET/CT, which enhance diagnostic capabilities for conditions related to cancer, ophthalmology, and neurological disorders. Key factors propelling this market include rapid technological advancements in diagnostic imaging, an aging population, escalating healthcare costs, and the rising incidence of chronic diseases. Between 2021 and 2028, innovations in technical development and modern healthcare practices are expected to create further opportunities for multimodal imaging applications. This sector is adapting to evolving consumer needs with the introduction of new contrast agents, advanced detectors, and computer-aided tools, ensuring precise treatment delivery to patients. Additionally, the development of sophisticated multimodal imaging techniques, such as hybrid optoacoustic fluorescent imaging, which utilizes dual-function chemical dyes, showcases the potential for enhanced diagnostic precision. The increasing demand for hybrid contrast agents characterized by variable spectra and photostability, alongside the growth of nanoparticles, underscores the market's revenue momentum. However, challenges such as the high costs of multimodal imaging equipment and insufficient healthcare infrastructure may impede growth. Despite these hurdles, the U.S. multimodal imaging market is expected to grow at a sustainable compounded annual growth rate (CAGR) in the upcoming forecast years, indicating a resilient outlook amidst evolving healthcare dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Multimodal Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Multimodal Imaging Market Segmental Analysis

Global Multimodal Imaging Market is segmented by Technology, Application, End User, and region. Based on Technology, the market is segmented into PET/CT, PET/MR, SPECT/CT, OCT/FMT, and Other multimodal imaging. Based on Application, the market is segmented into Brain & Neurology, Cardiology, Oncology, Ophthalmology, Research Applications, and Other Applications. Based on End Use, the market is segmented into Hospitals, Diagnostic Imaging Centers, Research and Academic Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Multimodal Imaging Market

The global multimodal imaging market is poised for significant growth driven by the increasing prevalence of chronic conditions such as cancers, cardiovascular diseases, and neurological disorders. As healthcare providers recognize the need for accurate and comprehensive diagnostics, the demand for advanced multimodal imaging systems is soaring. This technology enables clinicians to integrate various imaging modalities, enhancing the identification and monitoring of chronic diseases. Furthermore, the rise in respiratory ailments, including lung cancer and COPD, is contributing to the urgent need for innovative diagnostic tools. Consequently, the escalating demand for efficient cancer screening and comprehensive disease management will propel the growth of the multimodal imaging market over the forecast period.

Restraints in the Global Multimodal Imaging Market

The Global Multimodal Imaging market faces significant restraints primarily due to the high costs associated with imaging tools and methods, which burden both patients and healthcare providers. Equipment prices, such as those for PET/CT scans ranging from $75,000 to $500,000 and gamma cameras costing between $400,000 and $600,000, pose affordability challenges, particularly in price-sensitive developing countries like India. Consequently, many healthcare facilities rely on refurbished equipment, hindering market growth. Additionally, ongoing annual maintenance costs-covering preventive upkeep, labor, and technician fees-further escalate expenses for end users. This financial strain diminishes the frequency of multimodal imaging utilization, especially in lower-income regions, ultimately stymying market expansion.

Market Trends of the Global Multimodal Imaging Market

The global multimodal imaging market is poised for significant growth, driven by ongoing technological advancements in diagnostic equipment. Innovations aimed at enhancing image quality while reducing diagnostic costs are revolutionizing patient care. Key developments include the emergence of portable imaging solutions, 5D ultrasound technology, and advancements in digital X-ray systems equipped with wireless DR detectors. The integration of three-dimensional (3D), four-dimensional (4D), and five-dimensional (5D) imaging capabilities allows for more precise diagnoses. Furthermore, companies are leveraging cutting-edge technologies such as cloud computing and artificial intelligence (AI) to refine their product offerings, positioning the multimodal imaging market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Case Study Analysis
• Pricing Analysis

Multimodal Imaging Market, By Technology

• Market Overview
• PET/CT Systems
• SPECT/CT Systems
• PET/MR Systems
• OCT/FMT Systems
• Other Multimodal Imaging Systems

Multimodal Imaging Market, By Application

• Market Overview
• Oncology
• Cardiology
• Ophthalmology
• Brain & Neurology
• Research
• Other Applications

Multimodal Imaging Market, By End User

• Market Overview
• Hospitals
• Diagnostic Imaging Centers
• Academic & Research Institutes
• Other End Users

Multimodal Imaging Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeiss Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infraredx, Inc. (part of Nipro Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topcon Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai United Imaging Healthcare Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heidelberg Engineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Dynamics Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minfound Medical Systems Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindsway Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Corporation.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments